As Lewis Moody prepares to complete his epic 500-mile cycling challenge at Twickenham on Saturday, he's left an indelible mark on the world of rugby – and beyond. The former England captain's seven-day odyssey has raised a staggering £350k for motor neurone disease (MND) research, with his own battle against the condition serving as a beacon of hope.
Moody, the 2003 World Cup winner, described the experience as an 'emotional tidal wave' after completing stage five at Bath Rugby Club – but it's the unyielding sense of purpose driving him forward that's truly inspiring. "I'm in this MND space now and I've got the platform to amplify the noise," he declared, paying tribute to the likes of Doddie Weir and Rob Burrow, who left an enduring legacy in their fight against the disease.
The 'noise' Moody refers to is a cacophony of fundraising efforts that have catapulted MND research onto the national stage. Weir's charity has shattered all records with £23.5 million raised since his passing in 2022, while Kevin Sinfield's tributes to Burrow have topped £11 million. Moody's own 'Lewis Moody XV Ride' has drawn widespread support, with Kathy and Hamish Weir joining him from the outset – and an army of former England teammates, including Martin Johnson, Martin Corry, and Kenny Logan, providing a constant source of encouragement.
Moody's emphasis on securing further funding is backed by hard facts: more effective treatments are within reach, and life-extending breakthroughs could be achieved in the near future – but they need it. As he looks to the finish line, Moody remains resolute, aware that every penny counts towards the ultimate goal of beating MND.
Moody's ride is a potent reminder of the importance of community and collective endeavour in the face of adversity. And as he delivers the match ball before the Gallagher Prem Cup final at Twickenham, it will be a moment of pure triumph – but also a poignant acknowledgement that there's still so much to be done.
The My Name'5 Doddie Foundation continues its vital work in funding research into MND, a progressive neurodegenerative condition with no cure yet in sight. But with Moody and others at the forefront of this fight, the odds are slowly but surely shifting – and there's hope on the horizon for those affected by this devastating disease.